Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
INHIBITION OR TREATMENT OF DYSKINESIA
Document Type and Number:
WIPO Patent Application WO2006087577
Kind Code:
A3
Abstract:
Prevention or treatment of dyskinesia induced by L-dopa or dopamine agonist can be effected by use of a selective inhibitor of neuronal nitric oxide synthase.

Inventors:
IRVANI MAHMOUD (GB)
JENNER PETER (GB)
Application Number:
PCT/GB2006/000583
Publication Date:
October 19, 2006
Filing Date:
February 20, 2006
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
PROXIMAGEN LTD (GB)
IRVANI MAHMOUD (GB)
JENNER PETER (GB)
International Classes:
A61K31/00; A61K31/195; A61K45/06; A61P25/14
Domestic Patent References:
WO2004073712A12004-09-02
WO1998034919A11998-08-13
WO1998024766A11998-06-11
WO1997036871A11997-10-09
WO2003030993A12003-04-17
WO2005026111A22005-03-24
Foreign References:
US20030087891A12003-05-08
US20010034348A12001-10-25
US6235747B12001-05-22
US20030119751A12003-06-26
US6274557B12001-08-14
Other References:
ITOKAWA ET AL: "Effect of l-DOPA on nitric oxide production in striatum of freely mobile mice", NEUROSCIENCE LETTERS, LIMERICK, IE, vol. 402, no. 1-2, 10 July 2006 (2006-07-10), pages 142 - 144, XP005457923, ISSN: 0304-3940
PAVON ET AL: "ERK Phosphorylation and FosB Expression Are Associated with L-DOPA-Induced Dyskinesia in Hemiparkinsonian Mice", BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE, NEW YORK, NY, US, vol. 59, no. 1, 1 January 2006 (2006-01-01), pages 64 - 74, XP005229854, ISSN: 0006-3223
NEL A ET AL: "Haloperidol-induced dyskinesia is associated with striatal NO synthase suppression: reversal with olanzapine.", BEHAVIOURAL PHARMACOLOGY. MAY 2003, vol. 14, no. 3, May 2003 (2003-05-01), pages 251 - 255, XP009070205, ISSN: 0955-8810
Download PDF:



 
Previous Patent: IMPROVED OIL/WATER SEPARATOR

Next Patent: LATCH ASSEMBLY